Protalix Biotherapeutics Inc (PLX) is near the bottom in its industry group according to InvestorsObserver. PLX gets an overall rating of 30. That means it scores higher than 30 percent of stocks. Protalix Biotherapeutics Inc gets a 24 rank in the Biotechnology industry. Biotechnology is number 109 out of 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 30 means the stock is more attractive than 30 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Protalix Biotherapeutics Inc Stock Today?
Protalix Biotherapeutics Inc (PLX) stock is trading at $2.15 as of 2:50 PM on Wednesday, Jun 9, a rise of $0.05, or 2.38% from the previous closing price of $2.10. The stock has traded between $2.06 and $2.21 so far today. Volume today is high. So far 5,066,840 shares have traded compared to average volume of 2,496,506 shares.
Click Here to get the full Stock Score Report on Protalix Biotherapeutics Inc (PLX) Stock.
